Page last updated: 2024-11-02

piperazine and Pancreatic Neoplasms

piperazine has been researched along with Pancreatic Neoplasms in 3 studies

Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Akl, L1
Abd El-Hafeez, AA1
Ibrahim, TM1
Salem, R1
Marzouk, HMM1
El-Domany, RA1
Ghosh, P1
Eldehna, WM1
Abou-Seri, SM1
Laskowska, AK1
Puszko, AK1
Sosnowski, P1
Różycki, K1
Kosson, P1
Matalińska, J1
Durlik, M1
Misicka, A1
Pati, ML1
Hornick, JR1
Niso, M1
Berardi, F1
Spitzer, D1
Abate, C1
Hawkins, W1

Other Studies

3 other studies available for piperazine and Pancreatic Neoplasms

ArticleYear
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
    European journal of medicinal chemistry, 2022, Dec-05, Volume: 243

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro

2022
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
    European journal of medicinal chemistry, 2022, Dec-05, Volume: 243

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro

2022
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
    European journal of medicinal chemistry, 2022, Dec-05, Volume: 243

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro

2022
Identification of novel piperazine-tethered phthalazines as selective CDK1 inhibitors endowed with in vitro anticancer activity toward the pancreatic cancer.
    European journal of medicinal chemistry, 2022, Dec-05, Volume: 243

    Topics: Antineoplastic Agents; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Pro

2022
Opioid Tripeptides Hybridized with trans-1-Cinnamylpiperazine as Proliferation Inhibitors of Pancreatic Cancer Cells in Two- and Three-Dimensional in vitro Models.
    ChemMedChem, 2017, 10-09, Volume: 12, Issue:19

    Topics: Amino Acid Sequence; Analgesics, Opioid; Cell Culture Techniques; Cell Line; Cell Proliferation; Cel

2017
Sigma-2 receptor agonist derivatives of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) induce cell death via mitochondrial superoxide production and caspase activation in pancreatic cancer.
    BMC cancer, 2017, 01-13, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferati

2017